PT3065749T - Composição farmacêutica que compreende saccharomyces boulardii para redução da gordura corporal - Google Patents

Composição farmacêutica que compreende saccharomyces boulardii para redução da gordura corporal

Info

Publication number
PT3065749T
PT3065749T PT148085228T PT14808522T PT3065749T PT 3065749 T PT3065749 T PT 3065749T PT 148085228 T PT148085228 T PT 148085228T PT 14808522 T PT14808522 T PT 14808522T PT 3065749 T PT3065749 T PT 3065749T
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
body fat
reducing body
reducing
fat
Prior art date
Application number
PT148085228T
Other languages
English (en)
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Publication of PT3065749T publication Critical patent/PT3065749T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT148085228T 2013-11-08 2014-11-07 Composição farmacêutica que compreende saccharomyces boulardii para redução da gordura corporal PT3065749T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20130306537 EP2870969A1 (fr) 2013-11-08 2013-11-08 Composition pharmaceutique pour la réduction de la masse adipeuse

Publications (1)

Publication Number Publication Date
PT3065749T true PT3065749T (pt) 2020-09-28

Family

ID=49622767

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148085228T PT3065749T (pt) 2013-11-08 2014-11-07 Composição farmacêutica que compreende saccharomyces boulardii para redução da gordura corporal

Country Status (9)

Country Link
US (1) US20160287649A1 (pt)
EP (2) EP2870969A1 (pt)
CA (1) CA2929197C (pt)
DK (1) DK3065749T3 (pt)
ES (1) ES2821386T3 (pt)
LT (1) LT3065749T (pt)
PL (1) PL3065749T3 (pt)
PT (1) PT3065749T (pt)
WO (1) WO2015067788A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3685681B1 (en) * 2019-01-23 2024-07-31 Lesaffre et Compagnie A yeast product, and a composition comprising it, for use as a prebiotic agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0956867A1 (de) * 1998-05-12 1999-11-17 Franz-Peter Dr. Liebel Verwendung von Flavonoidglykosiden, Gerbstoffen und Mikroorganismen zur Therapie und Prophylaxe des Diabetes mellitus
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
FR2919187B1 (fr) * 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
WO2010119424A2 (fr) * 2009-04-15 2010-10-21 Exichol Sa Composition destinee a la regulation du metabolisme des lipides
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
EP3593811A1 (en) * 2012-09-20 2020-01-15 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions

Also Published As

Publication number Publication date
ES2821386T3 (es) 2021-04-26
LT3065749T (lt) 2020-12-10
PL3065749T3 (pl) 2021-01-25
EP3065749B1 (fr) 2020-06-24
WO2015067788A1 (fr) 2015-05-14
US20160287649A1 (en) 2016-10-06
EP2870969A1 (fr) 2015-05-13
CA2929197C (fr) 2022-07-12
CA2929197A1 (fr) 2015-05-14
EP3065749A1 (fr) 2016-09-14
DK3065749T3 (da) 2020-09-28

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical preparations
PL3030262T3 (pl) Złożona kompozycja farmaceutyczna
ZA201506487B (en) Therapeutic compounds and compositions
IL251448B (en) A preparation for use in reducing body fat in a patient
PL2943181T3 (pl) Kompozycje farmaceutyczne
ZA201408333B (en) Pharmaceutical compositions
GB201308131D0 (en) Ophthalmoscope
PL2839750T3 (pl) Kompozycja tłuszczowa
AP2015008875A0 (en) Low dose pharmaceutical composition
PL2956010T5 (pl) Kompozycja tłuszczów
GB2510587B (en) Biospecific agents for bone
SG11201601477VA (en) Pharmaceutical composition
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
ZA201600027B (en) Pharmaceutical preparation
HUP1300496A2 (hu) Stabil kombinációs gyógyszerkészítmény
IL244365A0 (en) pharmaceutical preparation
AP2015008890A0 (en) Pharmaceutical compositions
LT3065749T (lt) Farmacinė kompozicija, apimanti saccharomyces boulardii kūno riebalų mažinimui
GB201304699D0 (en) Pharmaceutical compositions
ZA201506465B (en) Pharmaceutical preparation
GB201304625D0 (en) New pharmaceutical composition
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions
GB201320786D0 (en) Medicament